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Summary. Colonic carcinoma was induced in male 
Sprague-Dawley rats by injecting them with 1,2- 
dimethylhydrazine dihydrochloride. Control rats were 
injected with EDTA solution. Tissue specimens of colon 
from four groups of animals: (i) rats without tumour, (ii) 
with dysplasia and lymphoid hyperplasia, (iii) with 
colonic adenocarcinoma, and (iv) controls,  were 
investigated. The colonic endocrine cells were detected 
by immunocytochemistry and quantified by 
computerised image analysis. Peptide YY (PYY)- and 
serotonin-immunoreactive cells were found in the colon 
of al1 the groups investigated. There were few 
somatostatin- or enteroglucagon-immunoreactive cells 
and no pancreatic polypeptide (PP)-immunoreactive 
cells in the colon of any of the groups studied. The 
density of PYY-immunoreactive cel ls  increased 
significantly in rats with dysplasia and lymphoid 
hyperplasia and in rats with colon carcinoma. There was 
no statistically significant difference as regards cell 
secretory index (CSI) or  nuclear area of PYY- 
immunoreactive cells in any of treated groups examined. 
Nor was there any statistically significant difference 
between al1 treated animal groups and controls, as 
regards cell density, CSI, or nuclear area of serotonin- 
immunoreactive cells. The present observations in an 
animal model of human colon carcinoma support the 
assumption that neuroendocrine peptides in the gut are 
involved in the carcinogenesis of colorectal carcinoma. 
However, The nature of the changes in the colonic 
endocrine cells observed here differed from those in 
patients with colon carcinoma, possibly due to a 
difference between the response of young rats to an 
induced colon carcinoma and a spontaneously developed 
carcinoma in elderly humans, or due to a species 
difference. 
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lntroductlon 
Several neuroendocrine peptides in the gut have 
been reported to affect the development and growth of 
colorectal carcinoma (Kusyk et al., 1986; Winsettet al., 
1986; Lamote and Willens, 1988; Guo et al., 1990; 
Narayan et al., 1990; Tausuta et al., 1990; Qin et al., 
1991, 1992; Van-Tol et al., 1991; Dy et al., 1992; Gamet 
et al., 1992; Yoshinaga et al., 1992; Ruszniewski et al., 
1993; Radulovic et al., 1994; Di-Paolo et al., 1995; Iishi 
et al., 1995; Stewart et al., 1995; Robbins, 1996). Thus, 
gastrin, neurotensin and bombesinlgastrin-releasing 
peptide (GRP) have been found to promote the 
proliferation and growth of colon cancer cells in humans 
and other animals (Kusyk et al., 1986; Winsett et al., 
1986; Lamote and Willens, 1988; Smith and Solomon, 
1988; Guo et al., 1990; Narayan et al., 1990; Tausuta et 
al., 1990; Alonos et al., 1992; Yoshinaga et al., 1992). In 
contrast, somatostatin analogues, galanin and vasoactive 
intestinal polypeptide (VIP), have been reported to 
inhibit the growth of human and rat colon cancer cells, 
both in xenografts and in vitro (Kusyk et al., 1986; 
Winsettet al., 1986; Lamote and Willens, 1988; Smith 
and Solomon, 1988; Guo et al., 1990; Narayan et al., 
1990; Tausuta et al., 1990; Qin et al., 1991, 1992; Van- 
Tol et al., 1991; Dy et al., 1992; Gamet et al., 1992; 
Yoshinaga e t  al., 1992; Ruszniewski et al., 1993; 
Radulovic et al., 1994; Di-Paolo et al., 1995; Iishi et al., 
1995;  Stewart  e t  al., 1995; Robbins, 1996). 
Consequently, recent findings of reduced somatostatin, 
galanin and serotonin in patients with colorectal 
carcinoma (El-Salhy et al., 1998a-c) and abnormal 
colonic levels of neuroendocrine peptides in rats with 
chemically-induced colon carcinoma (El-Salhy and 
Wilander, 1999) suggest that the neuroendocrine 
peptideslamines may play a significant role in colon 
carcinoma development and growth. 
Chemically-induced colonic carcinoma in rats has 
been used in several studies as a model for human colon 
carcinoma (Habs and Schmihl,  1978; Bansal et al., 
1978) and has been claimed to have histological, 
histochemical,  ultrastructural,  cytokinetic and 
histogenetic features similar to human neoplasm (Spjut 
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and Smith, 1967; Wiebeck et al., 1973; Filip, 1975; 
Pozharisski, 1975; Cole, 1978; Shamsuddin and Trump, 
1981; Ward and Ohishima, 1985; Traynor et al., 1986; 
McGarrity et al., 1987; Shetye et al., 1990). The present 
study was undertaken to ascertain whether colonic 
endocrine cells are affected in this animal model, as has 
been described in patients with colon carcinoma (El- 
Salhy et al., 1998a-c). 
Material and methods 
Animals 
Colon carcinoma was induced in 7-week-old male 
Sprague-Dawley rats (Mollegaard Breeding and 
Research Centre A/s, Denmark) weighing about 200 g, 
as described in details earlier (El-Salhy and Wilander, 
1999) Briefly, the rats were injected S.C. once a week for 
1 2  weeks with 2 1  mglkg body weight of 1 ,2  
dimethylhydrazine dihydrochloride (M.W. 133.2, Sigma, 
Stockholm) suspended in 1 m1 of EDTA solution as a 
stabilising agent. For control purposes, 15 rats were 
injected S.C. with 1 m1 of EDTA solution over the same 
period, at the end of which, al1 the rats were killed by 
exposure to C 0 2 .  The  gastrointestinal tract was 
dissected, rinsed in 0.9% saline solution and inspected 
for possible tumours. In rats with suspected tumours in 
the colon, tissue specimens from the colon, 3 cm from 
the tumour, and from proximal colon of the controls 
were dissected and fixed overnight in 4% buffered 
formaldehyde, dehydrated, embedded in paraffin wax, 
and cut into 5 pm-thick sections. The sections were 
stained with haematoxylin-eosin and van Gieson stains. 
The colonic endocrine cells were investigated in 8 
controls, 8 treated rats without histological changes, 6 
rats with colonic dysplasia and lymphoid hyperplasia, 
and 6 rats with colonic adenocarcinoma. 
lmmunocytochemistry 
The sections from the colon of al1 animal groups 
were immunostained with the avidin-biotin-complex 
(ABC) method (Dakopatts, Glostrup, Denmark) as 
described earlier in detail (El-Salhy and Suhr, 1996). 
The primary antibodies used were anti-peptide YY 
(PYY), anti-pancreatic polypeptide (PP), anti-glucagon, 
anti-somatostatin and anti-serotonin. A detailed account 
Table 1. Detailed account of the antisera used. 
of the antisera used is given in Table 1. Specificity 
controls were the same as those described previously 
(El-Salhy and Suhr, 1996). Briefly, the sections were 
incubated with non-immune serum instead of the 
primary antibodies, or with the primary antibody pre- 
incubated with the corresponding or structurally related 
antigen. 
Computerised image analysis 
This was performed by the Quantimet 500MC image 
processing and analysis system (Leica, Cambridge, 
England) linked to an Olympus microscope, type BX50. 
The program used in this system is QWIN (Leica's 
Windows-based image analysis tool kit, version 1.02). In 
addition, the system included QUIPS (version 1.02), an 
interactive programming system. The slides were coded 
and the performer was not aware of the identity of the 
sections. Measurements were performed with x20 and 
x40 objectives. At these magnifications, each pixel of 
the image corresponds to 0.414 and 0.21 /m,  
respectively and each field in the monitor represented a 
tissue area of 0.04 and 0.009 mm2, respectively. 
Measurements were made in 20 randomly chosen fields 
for each individual and peptide. These fields were 
selected from three to four sections, 50 p m  apart. 
The parameters measured were the number of 
immunoreactive cells, the area of epithelial cells, the 
area of immunoreactively stained secretory parts, and the 
nuclear area of immunoreactive cells. Using QUIPS, an 
automated standard sequence analysis operation was 
created as described earlier in detail (El-Salhy et al., 
1997). Briefly, the number of the immunoreactive cells 
was counted using field measurements. The areas of the 
epithelial cells and the immunoreactively stained 
secretory areas were measured using a threshold setting. 
The data from each field were tabulated, computed and 
statistically analysed automatically. The  section 
thickness was determined in the microscope by reading 
screw at the upper and lower section surfaces as  
described previously (Pinto et al., 1995) . The number of 
various endocrine cellslmm3 of the epithelial cells was 
estimated as described previously (El-Salhy et al., 1997). 
The CSI was calculated by the previously described 
formula (El-Salhy et al., 1997) as  follows: CSI = 
VSICN, where VS = the volume of the immunoreactive 
area in randomly selected cells expressed in pm3, and 
- 
ANTISERA AGAINST WORKING DlLUTlON CODENo. SOURCE 
Synthetic polypeptide W (PYY), (P) 1:1500 852-1 Eurodiagnostica, MalmS, Sweden 
Synthetic human pancreatic polypeptide (PP), (P) 1:lOOO A61 9 Dakopatts, Glostrup, Denmark 
Pancreatic porcine glucagonl (P) 1 :2500 8-31 Eurodiagnostica 
Synthetic human somatostatin (P) 1:1600 A566 Dakopatts 
Serotonin (M) 1:1500 M869 Dakopatts 
(P): polyclonal antibodies; (M): monoclonal antibodies. l: specific for glucagon N-tenninus and cross-reacts with both pancreatic glucagon and 
enteroglucagon. 
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CN = the number of cells measured. The nuclear areas of Statistical analysis 
10 randomly chosen cells for each individual and 
peptidelamine were measured using manual menu and Comparison between treated rats and controls was 
field measurements with a x40 objective. performed with the Wilcoxon non-parametric test. P- 
values below 0.05 were considered 
significan t. 
Results 
Immunocytochemístry 
Numerous PYY- (Fig.1) and serotonin- 
immunoreactive cells were found in the 
colon of al1 the animal groups investigated. 
Somatostatin- and enteroglucagon- 
immunoreactive cells were few, which 
precluded al1 further quantification. PP- 
immunoreactive cells could not be detected 
in the colon of any animal groups studied, 
which agrees with previous observations 
(El-Salhy and Lundquist, 1984). 
Computerised image analysis 
The results of the morphometric 
analyses are shown in Fig. 2. The density 
of PYY-immunoreactive cells increased 
significantly in rats with dysplasia and 
lymphoid hyperplasia and in rats with 
colon carcinoma (P=0.002 and 0.02, 
respectively). There was no statistically 
significant difference between controls and 
treated rats that did not develop macro- or 
groups examined and controls. Nor was 
there any statistically significant difference 
between al1 the treated animal groups and 
controls regarding cell density, CSI or 
nuclear area of serotonin-immunoreactive 
cells. 
Discussion 
In the present investigation, abnormal 
colonic endocrine cells were observed in 
rats with colonic dysplasia and lymphoid 
hyperplasia, and with colonic carcinoma, 
though not in rats treated with the same 
carcinogen but without developing any 
Flg. 1. PW-immunoreactive cells in the colon of a 
control rat (A) and of a rat with colonic 
adenocarcimmia (8). x 400 
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signs of neoplasm. This finding indicates that this 
alteration in colonic endocrine cells is connected with 
the development of carcinoma and is not an effect of the 
carcinogenic substance, 1,2 dimethylhydrazine 
dihydrochloride, on colonic endocrine cells. The present 
observation of high density of PYY-immunoreactive 
cells in the colon of rats that developed colonic dysplasia 
and lymphoid hyperplasia, as well as colonic carcinoma 
is consistent with previous radio-immunoassay results 
(El-Salhy and Wilander, 1999). PYY is known for its 
anti-secretory effect (Rangachari, 1991), delays 
intestinal transit, and is considered to be one of the 
mediators of the ileal brake (Mannon and Talyor, 1994) 
The possible role played by PYY in the development of 
PYY Serotonin 
Flg. 2. Morphometric 
measurements of cell density 
(A), cell secretoiy index (B), 
and nuclear area (C) of PW- 
imrnunoreactive cells, and cell 
density (D), the cell secretory 
index (E) and nuclear area (F) 
of serotonin-immunoreactive 
cells. The top, bottom, and line 
through the mlddle of the box 
correspond to the 75th 
percentile, the 25th percentile 
and 50th percentile (median). 
The whiskers on the bottom 
extend from the 10th percentile 
and top the 90th percentile. The 
black box represents the 
arithrnetic rnean. *: p<0.05; 
**: p<o.o1. 
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colon carcinoma remains to be determined. 
The present observation of abnormal colonic  
endocrine cells in an animal model of human colon 
carcinoma, together with earlier findings in the colon of 
patients with colon carcinoma (El-Salhy, et al., 1998a), 
support the assumption that neuroendocrine peptides in 
the gut are involved in the carcinogenesis of colorectal 
carcinoma (El-Salhy et al., 1998a-c). It is noteworthy, 
however, that the endocrine cell type and nature of the 
changes in the colonic endocrine cells observed here, 
differed from those observed in patients with colon 
carcinoma (El-Salhy et al., 1998a,c). Thus, whereas 
somatostatin- and serotonin-immunoreactive cell  
densities were low in the colon of patients with colon 
carcinoma (El-Salhy et al., 1998a), their density was not 
affected in rats with dysplasia and lymphoid hyperplasia, 
or in rats with colon carcinoma. Moreover, the density of 
PYY-immunoreactive cells was high in rats with 
dysplasia and lymphoid hyperplasia and in rats with 
colon carcinoma, but was unaffected in the colon of 
patients with colon carcinoma (El-Salhy et al., 1998a). It 
is worth noting that the age  of rats used in this 
investigation was about 5 months at the end of the 
experiments. The 50% survival point of male Sprague- 
Dawley rats is 30 months and the survival dips steeply at 
25 months (Kaspariet et al., 1989). Thus, the changes in 
the colonic endocrine cells observed in rats studied here 
represent a response of young rats to an induced colon 
carcinoma rather than a spontaneously developed 
carcinoma in elderly humans as reported previously (El- 
Salhy et al., 1998a-c). One can not, however, rule out the 
possibility that this was due to species differences. 
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